Drug Utilization Study for Olodaterol

Trial Profile

Drug Utilization Study for Olodaterol

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2017

At a glance

  • Drugs Olodaterol (Primary) ; Indacaterol
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 02 Nov 2017 Status changed from recruiting to active, no longer recruiting.
    • 01 Mar 2017 Status changed from not yet recruiting to recruiting.
    • 23 Feb 2017 Planned number of patients changed from 2000 to 20000.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top